TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs214803
log Bayes Factor = 38.436
Chromosome 20   position 2,290,333  (GRCh37) Explore rs214803 on Ensembl!
Variant rs214803 is part of Cluster X0017

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
C44.5 Skin of trunk
1.000 0.000 0.000
C44.3 Skin of other and unspecified parts of face
1.000 0.000 0.000
C44 Other malignant neoplasms of skin
1.000 0.000 0.000
C44.6 Skin of upper limb, including shoulder
1.000 0.000 0.000
C44.4 Skin of scalp and neck
1.000 0.000 0.000
C44.7 Skin of lower limb, including hip
1.000 0.000 0.000
C44.2 Skin of ear and external auricular canal
0.999 0.001 0.000
C44.0 Skin of lip
0.970 0.030 0.000
C44.1 Skin of eyelid, including canthus
0.874 0.126 0.000
C44.9 Malignant neoplasm of skin, unspecified
0.856 0.144 0.000
Z45.8 Adjustment and management of other implanted devices
0.000 0.282 0.718
C44.8 Overlapping lesion of skin
0.717 0.283 0.000
C43-C44 Melanoma and other malignant neoplasms of skin
0.692 0.308 0.000
C43 Malignant melanoma of skin
0.625 0.375 0.000
C43.6 Malignant melanoma of upper limb, including shoulder
0.567 0.433 0.000
C43.3 Malignant melanoma of other and unspecified parts of face
0.555 0.445 0.000
C43.4 Malignant melanoma of scalp and neck
0.491 0.509 0.000
C43.1 Malignant melanoma of eyelid, including canthus
0.481 0.519 0.000
C43.2 Malignant melanoma of ear and external auricular canal
0.450 0.550 0.000
C43.8 Overlapping malignant melanoma of skin
0.448 0.552 0.000
C43.0 Malignant melanoma of lip
0.448 0.552 0.000
C43.5 Malignant melanoma of trunk
0.393 0.606 0.000
C43.9 Malignant melanoma of skin, unspecified
0.357 0.643 0.000
C43.7 Malignant melanoma of lower limb, including hip
0.314 0.686 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.903 0.097
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.905 0.095
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.906 0.094
Z45 Adjustment and management of implanted device
0.000 0.910 0.090
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.911 0.089
T39.1 4-Aminophenol derivatives
0.000 0.912 0.088
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.914 0.086
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.915 0.085
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.920 0.080
Z45.1 Adjustment and management of infusion pump
0.000 0.921 0.079
T40.2 Other opioids
0.000 0.921 0.079
T36 Poisoning by systemic antibiotics
0.000 0.923 0.077
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.923 0.077
T39.0 Salicylates
0.000 0.924 0.076
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.926 0.074
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.926 0.073
T40.4 Other synthetic narcotics
0.000 0.927 0.073
T43.2 Other and unspecified antidepressants
0.000 0.928 0.072
T46.1 Calcium-channel blockers
0.000 0.928 0.072
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.929 0.071
T39.4 Antirheumatics, not elsewhere classified
0.000 0.930 0.070
T39.2 Pyrazolone derivatives
0.000 0.930 0.070
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.931 0.069
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.932 0.067
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.932 0.067
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.932 0.067
T36.0 Penicillins
0.000 0.934 0.065
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.935 0.065
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.935 0.065
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.935 0.065
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.935 0.065
Z45.9 Adjustment and management of unspecified implanted device
0.000 0.935 0.064
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.936 0.064
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.936 0.064
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.936 0.064
T46.7 Peripheral vasodilators
0.000 0.936 0.064
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.936 0.064
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.936 0.064
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.936 0.064
T43.6 Psychostimulants with abuse potential
0.000 0.937 0.063
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.938 0.062
T40.8 Lysergide [LSD]
0.000 0.938 0.062
T40.7 Cannabis (derivatives)
0.000 0.938 0.062
T40.5 Cocaine
0.000 0.938 0.062
T40.3 Methadone
0.000 0.938 0.062
T40.1 Heroin
0.000 0.938 0.062
T40.0 Opium
0.000 0.938 0.062
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.938 0.062
T43.9 Psychotropic drug, unspecified
0.000 0.939 0.061
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.939 0.061
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.939 0.061
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.939 0.061
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.939 0.060
Z45.3 Adjustment and management of implanted hearing device
0.000 0.943 0.056
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.944 0.056
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.944 0.056
T36.9 Systemic antibiotic, unspecified
0.000 0.944 0.056
T36.8 Other systemic antibiotics
0.000 0.944 0.056
T36.7 Antifungal antibiotics, systemically used
0.000 0.944 0.056
T36.6 Rifamycins
0.000 0.944 0.056
T36.5 Aminoglycosides
0.000 0.944 0.056
T36.4 Tetracyclines
0.000 0.944 0.056
T36.3 Macrolides
0.000 0.944 0.056
T36.2 Chloramphenicol group
0.000 0.944 0.056
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.944 0.056
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.946 0.054
T38.1 Thyroid hormones and substitutes
0.000 0.946 0.053
T50.8 Diagnostic agents
0.000 0.947 0.053
T50.7 Analeptics and opioid receptor antagonists
0.000 0.947 0.053
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.947 0.053
T50.5 Appetite depressants
0.000 0.947 0.053
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.947 0.053
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.947 0.053
T50.1 Loop [high-ceiling] diuretics
0.000 0.947 0.053
T50.0 Mineralocorticoids and their antagonists
0.000 0.947 0.053
T40.6 Other and unspecified narcotics
0.000 0.948 0.052
D37-D48 Neoplasms of uncertain or unknown behaviour
0.052 0.948 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.949 0.051
Chapter II Neoplasms
0.051 0.949 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.949 0.051
T38.9 Other and unspecified hormone antagonists
0.000 0.949 0.051
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.949 0.051
T38.7 Androgens and anabolic congeners
0.000 0.949 0.051
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.949 0.051
T38.5 Other oestrogens and progestogens
0.000 0.949 0.051
T38.4 Oral contraceptives
0.000 0.949 0.051
T38.2 Antithyroid drugs
0.000 0.949 0.051
T38.0 Glucocorticoids and synthetic analogues
0.000 0.949 0.051
T50.4 Drugs affecting uric acid metabolism
0.000 0.950 0.049
T41.5 Therapeutic gases
0.000 0.951 0.048
T41.4 Anaesthetic, unspecified
0.000 0.951 0.048
T41.3 Local anaesthetics
0.000 0.951 0.048
T41.2 Other and unspecified general anaesthetics
0.000 0.951 0.048
T41.1 Intravenous anaesthetics
0.000 0.951 0.048
T41.0 Inhaled anaesthetics
0.000 0.951 0.048
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.951 0.048
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.951 0.048
T48.5 Anti-common-cold drugs
0.000 0.951 0.048
T48.4 Expectorants
0.000 0.951 0.048
T48.3 Antitussives
0.000 0.951 0.048
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.951 0.048
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.951 0.048
T48.0 Oxytocic drugs
0.000 0.951 0.048
T49.9 Topical agent, unspecified
0.000 0.951 0.048
T49.8 Other topical agents
0.000 0.951 0.048
T49.7 Dental drugs, topically applied
0.000 0.951 0.048
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.951 0.048
T49.5 Ophthalmological drugs and preparations
0.000 0.951 0.048
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.951 0.048
T49.3 Emollients, demulcents and protectants
0.000 0.951 0.048
T49.2 Local astringents and local detergents
0.000 0.951 0.048
T49.1 Antipruritics
0.000 0.951 0.048
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.951 0.048
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.048 0.952 0.000
D45 Polycythaemia vera
0.048 0.952 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.953 0.047
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.953 0.047
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.953 0.047
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.953 0.047
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.953 0.047
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.953 0.047
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.953 0.047
T44.0 Anticholinesterase agents
0.000 0.953 0.047
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.954 0.046
T37.5 Antiviral drugs
0.000 0.954 0.046
T37.4 Anthelminthics
0.000 0.954 0.046
T37.3 Other antiprotozoal drugs
0.000 0.954 0.046
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.954 0.046
T37.1 Antimycobacterial drugs
0.000 0.954 0.046
T37.0 Sulphonamides
0.000 0.954 0.046
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs
0.045 0.955 0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites
0.045 0.955 0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.044 0.956 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.956 0.043
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.956 0.043
T47.7 Emetics
0.000 0.956 0.043
T47.6 Antidiarrhoeal drugs
0.000 0.956 0.043
T47.5 Digestants
0.000 0.956 0.043
T47.4 Other laxatives
0.000 0.956 0.043
T47.3 Saline and osmotic laxatives
0.000 0.956 0.043
T47.2 Stimulant laxatives
0.000 0.956 0.043
T47.0 Histamine H(2)-receptor antagonists
0.000 0.956 0.043
C69 Malignant neoplasm of eye and adnexa
0.043 0.957 0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs
0.043 0.957 0.000
T45.2 Vitamins, not elsewhere classified
0.000 0.957 0.042
D46 Myelodysplastic syndromes
0.043 0.957 0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs
0.043 0.957 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.958 0.042
D48.1 Connective and other soft tissue
0.042 0.958 0.000
C40-C41 Malignant neoplasms of bone and articular cartilage
0.042 0.958 0.000
T42.1 Iminostilbenes
0.000 0.958 0.042
C71 Malignant neoplasm of brain
0.041 0.959 0.000
T45.5 Anticoagulants
0.000 0.959 0.041
D38.1 Trachea, bronchus and lung
0.041 0.959 0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs
0.041 0.959 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.959 0.040
T45.8 Other primarily systemic and haematological agents
0.000 0.959 0.040
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.959 0.040
T45.6 Fibrinolysis-affecting drugs
0.000 0.959 0.040
T45.4 Iron and its compounds
0.000 0.959 0.040
T45.3 Enzymes, not elsewhere classified
0.000 0.959 0.040
C45-C49 Malignant neoplasms of mesothelial and soft tissue
0.040 0.960 0.000
T45.0 Antiallergic and antiemetic drugs
0.000 0.960 0.040
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system
0.040 0.960 0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.040 0.960 0.000
C34 Malignant neoplasm of bronchus and lung
0.040 0.960 0.000
D40.1 Testis
0.040 0.960 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.960 0.039
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.961 0.039
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.961 0.039
T42.3 Barbiturates
0.000 0.961 0.039
T42.2 Succinimides and oxazolidinediones
0.000 0.961 0.039
T42.0 Hydantoin derivatives
0.000 0.961 0.039
C34.0 Main bronchus
0.038 0.962 0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges
0.037 0.963 0.000
C71.3 Parietal lobe
0.037 0.963 0.000
C74 Malignant neoplasm of adrenal gland
0.037 0.963 0.000
C34.2 Middle lobe, bronchus or lung
0.037 0.963 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.963 0.036
D47.2 Monoclonal gammopathy
0.037 0.963 0.000
C69.9 Eye, unspecified
0.036 0.964 0.000
D48.6 Breast
0.036 0.964 0.000
C49 Malignant neoplasm of other connective and soft tissue
0.036 0.964 0.000
D43.1 Brain, infratentorial
0.036 0.964 0.000
C69.6 Orbit
0.035 0.965 0.000
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified
0.035 0.965 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.965 0.035
D46.9 Myelodysplastic syndrome, unspecified
0.035 0.965 0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system
0.035 0.965 0.000
C70 Malignant neoplasm of meninges
0.035 0.965 0.000
C73 Malignant neoplasm of thyroid gland
0.035 0.965 0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.035 0.965 0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs
0.034 0.965 0.000
C51-C58 Malignant neoplasms of female genital organs
0.034 0.966 0.000
C75 Malignant neoplasm of other endocrine glands and related structures
0.034 0.966 0.000
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands
0.034 0.966 0.000
D38.0 Larynx
0.033 0.966 0.000
C71.2 Temporal lobe
0.033 0.967 0.000
C31 Malignant neoplasm of accessory sinuses
0.033 0.967 0.000
D46.7 Other myelodysplastic syndromes
0.033 0.967 0.000
C71.0 Cerebrum, except lobes and ventricles
0.033 0.967 0.000
C69.3 Choroid
0.033 0.967 0.000
C38 Malignant neoplasm of heart, mediastinum and pleura
0.033 0.967 0.000
D48.2 Peripheral nerves and autonomic nervous system
0.033 0.967 0.000
C71.4 Occipital lobe
0.033 0.967 0.000
D38.6 Respiratory organ, unspecified
0.033 0.967 0.000
D38.5 Other respiratory organs
0.033 0.967 0.000
D38.4 Thymus
0.033 0.967 0.000
D38.3 Mediastinum
0.033 0.967 0.000
D38.2 Pleura
0.033 0.967 0.000
D48.4 Peritoneum
0.033 0.967 0.000
D48.3 Retroperitoneum
0.033 0.967 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.967 0.033
S32.00 Fracture of lumbar vertebra (closed)
0.000 0.967 0.033
D48.0 Bone and articular cartilage
0.032 0.967 0.000
T42.4 Benzodiazepines
0.000 0.968 0.032
D39.1 Ovary
0.032 0.968 0.000
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites
0.032 0.968 0.000
C74.9 Adrenal gland, unspecified
0.031 0.968 0.000
C69.8 Overlapping lesion of eye and adnexa
0.031 0.969 0.000
C69.5 Lachrymal gland and duct
0.031 0.969 0.000
C69.4 Ciliary body
0.031 0.969 0.000
C69.2 Retina
0.031 0.969 0.000
C69.1 Cornea
0.031 0.969 0.000
C69.0 Conjunctiva
0.031 0.969 0.000
D40.9 Male genital organ, unspecified
0.031 0.969 0.000
D40.7 Other male genital organs
0.031 0.969 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.031 0.969 0.000
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality
0.031 0.969 0.000
D46.5 Refractory anaemia with multi-lineage dysplasia
0.031 0.969 0.000
D46.4 Refractory anaemia, unspecified
0.031 0.969 0.000
D46.3 Refractory anaemia with excess of blasts with transformation
0.031 0.969 0.000
D46.1 Refractory anaemia with sideroblasts
0.031 0.969 0.000
D46.0 Refractory anaemia without sideroblasts, so stated
0.031 0.969 0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs
0.031 0.969 0.000
C33 Malignant neoplasm of trachea
0.031 0.969 0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs
0.031 0.969 0.000
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)
0.030 0.970 0.000
D39.0 Uterus
0.030 0.970 0.000
D46.2 Refractory anaemia with excess of blasts
0.030 0.970 0.000
C34.8 Overlapping lesion of bronchus and lung
0.030 0.970 0.000
C71.7 Brain stem
0.030 0.970 0.000
C71.6 Cerebellum
0.030 0.970 0.000
C71.5 Cerebral ventricle
0.030 0.970 0.000
C34.1 Upper lobe, bronchus or lung
0.030 0.970 0.000
C49.5 Connective and soft tissue of pelvis
0.029 0.971 0.000
D39.9 Female genital organ, unspecified
0.029 0.971 0.000
D39.7 Other female genital organs
0.029 0.971 0.000
D39.2 Placenta
0.029 0.971 0.000
C49.4 Connective and soft tissue of abdomen
0.029 0.971 0.000
C40.2 Long bones of lower limb
0.029 0.971 0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system
0.029 0.971 0.000
C46 Kaposi's sarcoma
0.029 0.971 0.000
D43.9 Central nervous system, unspecified
0.029 0.971 0.000
D43.7 Other parts of central nervous system
0.029 0.971 0.000
D43.4 Spinal cord
0.029 0.971 0.000
D43.3 Cranial nerves
0.029 0.971 0.000
D47.1 Chronic myeloproliferative disease
0.029 0.971 0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.029 0.971 0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]
0.029 0.971 0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour
0.029 0.971 0.000
C55 Malignant neoplasm of uterus, part unspecified
0.029 0.971 0.000
D43.0 Brain, supratentorial
0.029 0.971 0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
0.029 0.971 0.000
C49.2 Connective and soft tissue of lower limb, including hip
0.028 0.971 0.000
C56 Malignant neoplasm of ovary
0.029 0.971 0.000
C64-C68 Malignant neoplasms of urinary tract
0.028 0.972 0.000
C37 Malignant neoplasm of thymus
0.027 0.972 0.000
D48.7 Other specified sites
0.028 0.972 0.000
C49.3 Connective and soft tissue of thorax
0.027 0.973 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.027 0.973 0.000
C91 Lymphoid leukaemia
0.027 0.973 0.000
D42.9 Meninges, unspecified
0.027 0.973 0.000
D42.1 Spinal meninges
0.027 0.973 0.000
D42.0 Cerebral meninges
0.027 0.973 0.000
C71.8 Overlapping lesion of brain
0.027 0.973 0.000
C49.0 Connective and soft tissue of head, face and neck
0.027 0.973 0.000
C74.1 Medulla of adrenal gland
0.027 0.973 0.000
C74.0 Cortex of adrenal gland
0.027 0.973 0.000
C31.0 Maxillary sinus
0.026 0.973 0.000
D44.1 Adrenal gland
0.027 0.973 0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum
0.027 0.973 0.000
C75.9 Endocrine gland, unspecified
0.026 0.973 0.000
C30 Malignant neoplasm of nasal cavity and middle ear
0.026 0.973 0.000
D44.3 Pituitary gland
0.026 0.974 0.000
C91.1 Chronic lymphocytic leukaemia
0.026 0.974 0.000
C38.4 Pleura
0.026 0.974 0.000
C49.8 Overlapping lesion of connective and soft tissue
0.026 0.974 0.000
C49.6 Connective and soft tissue of trunk, unspecified
0.026 0.974 0.000
D48.5 Skin
0.026 0.974 0.000
C71.1 Frontal lobe
0.026 0.974 0.000
D47.3 Essential (haemorrhagic) thrombocythaemia
0.026 0.974 0.000
C57 Malignant neoplasm of other and unspecified female genital organs
0.026 0.974 0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.026 0.974 0.000
C45 Mesothelioma
0.025 0.975 0.000
C72.0 Spinal cord
0.025 0.975 0.000
C72.9 Central nervous system, unspecified
0.025 0.975 0.000
C72.8 Overlapping lesion of brain and other parts of central nervous system
0.025 0.975 0.000
C72.5 Other and unspecified cranial nerves
0.025 0.975 0.000
C72.4 Acoustic nerve
0.025 0.975 0.000
C72.3 Optic nerve
0.025 0.975 0.000
C72.2 Olfactory nerve
0.025 0.975 0.000
C72.1 Cauda equina
0.025 0.975 0.000
C70.9 Meninges, unspecified
0.025 0.975 0.000
C70.1 Spinal meninges
0.025 0.975 0.000
C70.0 Cerebral meninges
0.025 0.975 0.000
C40.9 Bone and articular cartilage of limb, unspecified
0.025 0.975 0.000
C40.8 Overlapping lesion of bone and articular cartilage of limbs
0.025 0.975 0.000
C40.3 Short bones of lower limb
0.025 0.975 0.000
C40.1 Short bones of upper limb
0.025 0.975 0.000
C40.0 Scapula and long bones of upper limb
0.025 0.975 0.000
C58 Malignant neoplasm of placenta
0.025 0.975 0.000
C66 Malignant neoplasm of ureter
0.025 0.975 0.000
C49.1 Connective and soft tissue of upper limb, including shoulder
0.025 0.975 0.000
C75.8 Pluriglandular involvement, unspecified
0.024 0.975 0.000
C75.5 Aortic body and other paraganglia
0.024 0.975 0.000
C75.4 Carotid body
0.024 0.975 0.000
C75.3 Pineal gland
0.024 0.975 0.000
C75.2 Craniopharyngeal duct
0.024 0.975 0.000
C75.1 Pituitary gland
0.024 0.975 0.000
C75.0 Parathyroid gland
0.024 0.975 0.000
D44.9 Endocrine gland, unspecified
0.024 0.975 0.000
D44.6 Carotid body
0.024 0.975 0.000
D44.5 Pineal gland
0.024 0.975 0.000
D44.2 Parathyroid gland
0.024 0.975 0.000
C49.9 Connective and soft tissue, unspecified
0.024 0.975 0.000
C52 Malignant neoplasm of vagina
0.024 0.976 0.000
D40.0 Prostate
0.024 0.976 0.000
C41.9 Bone and articular cartilage, unspecified
0.024 0.976 0.000
C41.1 Mandible
0.024 0.976 0.000
D44.7 Aortic body and other paraganglia
0.024 0.976 0.000
C31.9 Accessory sinus, unspecified
0.024 0.976 0.000
C31.8 Overlapping lesion of accessory sinuses
0.024 0.976 0.000
C31.3 Sphenoidal sinus
0.024 0.976 0.000
C31.2 Frontal sinus
0.024 0.976 0.000
C31.1 Ethmoidal sinus
0.024 0.976 0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura
0.024 0.976 0.000
C38.3 Mediastinum, part unspecified
0.024 0.976 0.000
C38.2 Posterior mediastinum
0.024 0.976 0.000
C38.1 Anterior mediastinum
0.024 0.976 0.000
C38.0 Heart
0.024 0.976 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.001 0.976 0.023
C81 Hodgkin's disease
0.024 0.976 0.000
C41.8 Overlapping lesion of bone and articular cartilage
0.023 0.977 0.000
C41.4 Pelvic bones, sacrum and coccyx
0.023 0.977 0.000
C41.3 Ribs, sternum and clavicle
0.023 0.977 0.000
C41.2 Vertebral column
0.023 0.977 0.000
C88 Malignant immunoproliferative diseases
0.023 0.977 0.000
D44.8 Pluriglandular involvement
0.023 0.977 0.000
C97 Malignant neoplasms of independent (primary) multiple sites
0.023 0.977 0.000
C83.3 Large cell (diffuse)
0.023 0.977 0.000
C93 Monocytic leukaemia
0.022 0.977 0.000
C32 Malignant neoplasm of larynx
0.022 0.977 0.001
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.022 0.977 0.000
C94 Other leukaemias of specified cell type
0.022 0.977 0.000
C86 Other specified types of T/NK-cell lymphoma
0.022 0.977 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.022 0.978 0.000
D44.0 Thyroid gland
0.022 0.978 0.000
C39.9 Ill-defined sites within the respiratory system
0.022 0.978 0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs
0.022 0.978 0.000
C39.0 Upper respiratory tract, part unspecified
0.022 0.978 0.000
D41.9 Urinary organ, unspecified
0.022 0.978 0.000
D41.7 Other urinary organs
0.022 0.978 0.000
D41.3 Urethra
0.022 0.978 0.000
D41.1 Renal pelvis
0.022 0.978 0.000
C42.4 hematopoietic and reticuloendothelial systems: Hematopoietic system, NOS (ICD-O-3 specific)
0.022 0.978 0.000
C42.3 hematopoietic and reticuloendothelial systems: Reticuloendothelial system, NOS (ICD-O-3 specific)
0.022 0.978 0.000
C42.2 hematopoietic and reticuloendothelial systems: spleen (ICD-O-3 specific)
0.022 0.978 0.000
C42.1 hematopoietic and reticuloendothelial systems: bone marrow (ICD-O-3 specific)
0.022 0.978 0.000
C42.0 hematopoietic and reticuloendothelial systems: blood (ICD-O-3 specific)
0.022 0.978 0.000
D43.2 Brain, unspecified
0.022 0.978 0.000
C41.0 Bones of skull and face
0.021 0.978 0.000
C53 Malignant neoplasm of cervix uteri
0.022 0.978 0.000
C50-C50 Malignant neoplasm of breast
0.021 0.978 0.000
C95 Leukaemia of unspecified cell type
0.021 0.978 0.000
D47.4 Osteomyelofibrosis
0.021 0.978 0.000
C65 Malignant neoplasm of renal pelvis
0.021 0.979 0.000
D41.2 Ureter
0.021 0.979 0.000
C68 Malignant neoplasm of other and unspecified urinary organs
0.021 0.979 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.021 0.979 0.000
C46.9 Kaposi's sarcoma, unspecified
0.021 0.979 0.000
C46.8 Kaposi's sarcoma of multiple organs
0.021 0.979 0.000
C46.7 Kaposi's sarcoma of other sites
0.021 0.979 0.000
C46.3 Kaposi's sarcoma of lymph nodes
0.021 0.979 0.000
C46.2 Kaposi's sarcoma of palate
0.021 0.979 0.000
C46.1 Kaposi's sarcoma of soft tissue
0.021 0.979 0.000
C46.0 Kaposi's sarcoma of skin
0.021 0.979 0.000
C47.9 Peripheral nerves and autonomic nervous system, unspecified
0.021 0.979 0.000
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system
0.021 0.979 0.000
C47.6 Peripheral nerves of trunk, unspecified
0.021 0.979 0.000
C47.5 Peripheral nerves of pelvis
0.021 0.979 0.000
C47.4 Peripheral nerves of abdomen
0.021 0.979 0.000
C47.3 Peripheral nerves of thorax
0.021 0.979 0.000
C47.2 Peripheral nerves of lower limb, including hip
0.021 0.979 0.000
C47.1 Peripheral nerves of upper limb, including shoulder
0.021 0.979 0.000
C47.0 Peripheral nerves of head, face and neck
0.021 0.979 0.000
C51 Malignant neoplasm of vulva
0.021 0.979 0.000
C71.9 Brain, unspecified
0.021 0.979 0.000
D44.4 Craniopharyngeal duct
0.020 0.979 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.021 0.979 0.000
C48.2 Peritoneum, unspecified
0.021 0.979 0.000
C83.0 Small cell (diffuse)
0.021 0.979 0.000
D41.0 Kidney
0.021 0.979 0.000
C08 Malignant neoplasm of other and unspecified major salivary glands
0.020 0.980 0.000
C02 Malignant neoplasm of other and unspecified parts of tongue
0.020 0.980 0.000
C91.5 Adult T-cell leukaemia
0.020 0.980 0.000
C04 Malignant neoplasm of floor of mouth
0.020 0.980 0.000
C13 Malignant neoplasm of hypopharynx
0.020 0.980 0.000
C83.6 Undifferentiated (diffuse)
0.020 0.980 0.000
C83.5 Lymphoblastic (diffuse)
0.020 0.980 0.000
C83.4 Immunoblastic (diffuse)
0.020 0.980 0.000
C83.2 Mixed small and large cell (diffuse)
0.020 0.980 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.019 0.980 0.000
C91.7 Other lymphoid leukaemia
0.019 0.980 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.019 0.980 0.000
C91.3 Prolymphocytic leukaemia
0.019 0.980 0.000
C91.2 Subacute lymphocytic leukaemia
0.019 0.980 0.000
C83.1 Small cleaved cell (diffuse)
0.019 0.981 0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum
0.019 0.981 0.000
C57.0 Fallopian tube
0.019 0.981 0.000
C30.1 Middle ear
0.019 0.981 0.000
C06 Malignant neoplasm of other and unspecified parts of mouth
0.019 0.981 0.000
D41.4 Bladder
0.019 0.981 0.000
C00 Malignant neoplasm of lip
0.019 0.981 0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
0.019 0.981 0.000
C81.0 Lymphocytic predominance
0.019 0.981 0.000
C91.9 Lymphoid leukaemia, unspecified
0.019 0.981 0.000
C91.4 Hairy-cell leukaemia
0.019 0.981 0.000
C81.1 Nodular sclerosis
0.019 0.981 0.000
C57.9 Female genital organ, unspecified
0.018 0.981 0.000
C57.8 Overlapping lesion of female genital organs
0.018 0.981 0.000
C57.7 Other specified female genital organs
0.018 0.981 0.000
C57.4 Uterine adnexa, unspecified
0.018 0.981 0.000
C57.3 Parametrium
0.018 0.981 0.000
C57.2 Round ligament
0.018 0.981 0.000
C57.1 Broad ligament
0.018 0.981 0.000
C03 Malignant neoplasm of gum
0.018 0.981 0.000
C48.0 Retroperitoneum
0.018 0.981 0.000
C45.9 Mesothelioma, unspecified
0.018 0.981 0.000
C45.2 Mesothelioma of pericardium
0.018 0.981 0.000
C45.1 Mesothelioma of peritoneum
0.018 0.981 0.000
C83.7 Burkitt's tumour
0.018 0.982 0.000
C32.1 Supraglottis
0.018 0.982 0.000
C60-C63 Malignant neoplasms of male genital organs
0.018 0.982 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.018 0.982 0.000
C34.9 Bronchus or lung, unspecified
0.018 0.982 0.000
C11 Malignant neoplasm of nasopharynx
0.018 0.982 0.000
C12 Malignant neoplasm of pyriform sinus
0.018 0.982 0.000
D00-D09 In situ neoplasms
0.018 0.982 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.017 0.982 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.017 0.982 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.017 0.982 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.017 0.983 0.000
C02.1 Border of tongue
0.017 0.983 0.000
C81.7 Other Hodgkin's disease
0.017 0.983 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.017 0.983 0.000
C81.3 Lymphocytic depletion
0.017 0.983 0.000
C81.2 Mixed cellularity
0.017 0.983 0.000
C10 Malignant neoplasm of oropharynx
0.017 0.983 0.000
C85.1 B-cell lymphoma, unspecified
0.017 0.983 0.000
C45.7 Mesothelioma of other sites
0.017 0.983 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.017 0.983 0.000
C88.7 Other malignant immunoproliferative diseases
0.017 0.983 0.000
C88.3 Immunoproliferative small intestinal disease
0.017 0.983 0.000
C88.2 Gamma heavy chain disease
0.017 0.983 0.000
C88.1 Alpha heavy chain disease
0.017 0.983 0.000
C05 Malignant neoplasm of palate
0.016 0.983 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.016 0.983 0.000
C93.1 Chronic monocytic leukaemia
0.016 0.983 0.000
C45.0 Mesothelioma of pleura
0.016 0.983 0.000
C93.9 Monocytic leukaemia, unspecified
0.016 0.984 0.000
C93.7 Other monocytic leukaemia
0.016 0.984 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.016 0.984 0.000
C93.2 Subacute monocytic leukaemia
0.016 0.984 0.000
C93.0 Acute monocytic leukaemia
0.016 0.984 0.000
C08.9 Major salivary gland, unspecified
0.016 0.984 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.